C
LIVE

Serial Number

98353713

Owner

Cellanome, Inc.

Attorney

Timothy D. Sitzmann

Filing Date

Jan 11, 2024

Add to watchlist:

No watchlists yet
View on USPTO

C Trademark

Serial Number: 98353713

C is a trademark filed by Cellanome, Inc. on January 11, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Cellanome, Inc. (5 trademarks)

500 Lincoln Centre Drive
Foster City, CA 94404

Entity Type: 03

Trademark Details

Filing Date

January 11, 2024

Registration Date

Not Registered

Goods & Services

Research laboratory analyzers for measuring, testing and analyzing biological samples, blood, and other bodily fluids and recorded computer software for operation and management of such research laboratory analyzers; laboratory equipment, namely, laboratory instrument, apparatus, and computer for genetic analysis, cellular analysis, DNA sequencing, and proteomic analysis and recorded computer software for operation and management of such equipment for performing cellular analysis; recorded computer software for medical and scientific research, for data management and analysis, data organization and storage, data sharing, and for analyzing biological samples, for operation of laboratory analyzers, for genetic analysis, and for performing cellular analysis; medical and scientific research and analysis in the fields of multiomics, cellular analysis, DNA sequencing, biomarkers, informatics, proteomics, genomics, secretomics, transcriptomics, and RNA sequencing

Reagents for medical purposes and medical diagnostic assays for testing of biological material; kits comprising chemical reagents, DNA or RNA sequences in the nature of microarray panels and cartridges, nucleic acids, enzymes, microfluidic chips, and nucleotides, all for medical purposes

Reagents and assays for research purposes; kits comprising chemical reagents, DNA sequences or RNA sequences in the nature of microarray panels and cartridges, nucleic acids, enzymes, microfluidic chips, and nucleotides, all for research, scientific, and industrial purposes

Medical testing services; medical information; medical services in the nature of testing, analyzing, reporting, and consulting services in the fields of genetic analysis, proteomic analysis, cellular analysis, multiomics, biomarkers, DNA sequencing, and informatics, proteomics, genomics, secretomics, transcriptomics, and RNA sequencing, all for medical purposes

Medical and scientific research; biomedical research and consulting services in the fields of cellular analysis, genetic analysis genomics, multiomics, biomarkers, DNA sequencing, informatics, proteomics, genomics, secretomics, transcriptomics, and RNA sequencing; providing software as a service featuring software for management and operation of laboratory equipment and laboratory analyzers; providing software as a service featuring software for research analysis and testing of cell characteristics in the field of cellular analysis, genetic analysis, genomics, multiomics, biomarkers, DNA sequencing, RNA sequencing, informatics, proteomics, secretomics, and transcriptomics; providing software as a service featuring software for analyzing biological samples and collecting, managing, sharing, and analyzing data and generating cellular images; providing software as a service featuring software for research analysis and cellular testing in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the fields of cellular analysis, genetic analysis, genomics, multiomics, biomarkers, DNA sequencing, and informatics, proteomics, secretomics, transcriptomics, and RNA sequencing for medical, scientific, and technological applications

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 24, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 24, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 24, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 22, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 12, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 12, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 12, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 7, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 9, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 9, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 9, 2024 COAR
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 5, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2024 NWOS
NEW APPLICATION ENTERED
Jan 11, 2024 NWAP